Bridgeway Capital Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1K | Sell |
56,081
-15,000
| -21% | -$10.2K | ﹤0.01% | 1146 |
|
|
2025
Q1 | $51.5K | Hold |
71,081
| – | – | ﹤0.01% | 1119 |
|
|
2024
Q4 | $67.9K | Hold |
71,081
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q3 | $56K | Hold |
71,081
| – | – | ﹤0.01% | 1205 |
|
|
2024
Q2 | $67.3K | Hold |
71,081
| – | – | ﹤0.01% | 1196 |
|
|
2024
Q1 | $76.8K | Sell |
71,081
-84,400
| -54% | -$91.2K | ﹤0.01% | 1237 |
|
|
2023
Q4 | $85.5K | Buy |
155,481
+45,000
| +41% | +$24.8K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $233K | Hold |
110,481
| – | – | 0.01% | 1068 |
|
|
2023
Q2 | $289K | Hold |
110,481
| – | – | 0.01% | 1055 |
|
|
2023
Q1 | $351K | Hold |
110,481
| – | – | 0.01% | 966 |
|
|
2022
Q4 | $297K | Buy |
110,481
+34,400
| +45% | +$92.5K | 0.01% | 992 |
|
|
2022
Q3 | $221K | Buy |
+76,081
| New | +$221K | 0.01% | 1122 |
|